HER2-expressing Cancers
3 clinical trials · Condition
◉ Watch HER2-expressing Cancers
| Record | Firm | Date |
|---|---|---|
| A Study of Zanidatamab (ZW25) With Evorpacept (ALX148) in Patients With Advanced HER2-expressing Cancer (NCT05027139) | Jazz Pharmaceuticals | 2021-09-15 |
| A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers (NCT03821233) | Zymeworks BC Inc. | 2019-04-15 |
| Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing Cancers (NCT02892123) | Jazz Pharmaceuticals | 2016-09-30 |
Track HER2-expressing Cancers automatically
Every clearance here is in the API, with alerts when new ones post.